Company: PTHS
Filing Date: 2025-05-27
Form Type: DEFM14C
Source: 0001140361-25-020509
Chunk: 218

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-27
Form: DEFM14C
Chunk 218
---
 each of Channel and LNHC caution you that the LNHC Projections should be evaluated, if at all, in conjunction with the historical financial statements and other information regarding LNHC contained elsewhere in this information

<div align='center'>120</div>

TABLE OF CONTENTS

statement. You are urged to read the sections entitled “ Cautionary Note Regarding Forward-Looking Statements” and “ Risk Factors” of this information statement, for additional information regarding the risks inherent in forward-looking information such as the LNHC Projections.

| ($ in mm)      |     |   2025E |     |   2026E |     |  2027E |     |   2028E |     |   2029E |     |   2030E |     |   2031E |     |   2032E |     |   2033E |     |   2034E |
| Net Revenue    |     |   $8.46 |     |  $47.63 |     | $95.38 |     | $144.75 |     | $167.48 |     | $194.14 |     | $211.30 |     | $225.41 |     | $248.02 |     | $263.89 |
| Gross Profit   |     |   $7.20 |     |  $42.38 |     | $86.23 |     | $132.35 |     | $153.22 |     | $178.28 |     | $195.18 |     | $208.30 |     | $229.07 |     | $243.83 |
| EBITDA         |     | -$35.65 |     |  -$7.13 |     | $28.18 |     |  $65.43 |     |  $81.47 |     | $101.03 |     | $108.00 |     | $117.48 |     | $133.19 |     | $143.96 |
| Net Income     |     | -$36.46 |     |  -$9.00 |     | $25.42 |     |  $61.75 |     |  $77.89 |     |  $97.58 |     | $106.54 |     | $115.93 |     | $131.54 |     | $142.20 |
| Free Cash Flow |     |